NASDAQ · Drug Manufacturers - Specialty & Generic

BioCryst Pharmaceuticals Inc (BCRX)

$9.55 -1.14%

Add alert

49 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$8.31+14.92%

Company profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Market cap$2.51B

P/E ratioNone

EPS$-1.47

Beta0.554

Dividend yield0.00%

52-week high$11.22

52-week low$6.00

Similar stocks in Drug Manufacturers - Specialty & Generic

HIMS Hims & Hers Health Inc - Class A RSI 58 CGC Canopy Growth Corporation RSI 64 BFRI Biofrontera Inc RSI 75 TLRY Tilray Brands Inc - Class 2 RSI 58 LNTH Lantheus Holdings Inc RSI 42 ACB Aurora Cannabis Inc RSI 73 INM InMed Pharmaceuticals Inc RSI 46 ORGO Organogenesis Holdings Inc - Class A RSI 35 ZTS Zoetis Inc - Class A RSI 57 AQST Aquestive Therapeutics Inc RSI 52

Free forever

RSI alerts for BCRX

Get an email the moment BioCryst Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 8:33 AM EDT